» Articles » PMID: 31118063

An Unusual Presentation of Purine Nucleoside Phosphorylase Deficiency Mimicking Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome

Overview
Publisher Biomed Central
Specialty Pediatrics
Date 2019 May 24
PMID 31118063
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Systemic juvenile idiopathic arthritis (sJIA) is an inflammatory condition that presents with fever, rash and arthritis. At onset systemic features are predominant and the diagnosis may be a challenge. Secondary hemophagocytic lymphohistiocytosis (sHLH) forms may be associated with different disorders, including rheumatic diseases, and this form is called macrophage activation syndrome (MAS). CXCL9 levels, a chemokine induced by IFNγ, are significantly elevated in patients with sHLH or MAS and are correlated with laboratory features of disease activity. High levels of IL-18 have been reported in patients with MAS during sJIA, as well as in some patients with sHLH and IL-18 is indeed known to induce IFNγ production.

Findings: We report a patient with a clinical presentation highly suggestive for systemic juvenile idiopathic arthritis (sJIA) onset complicated by MAS, and was later diagnosed with purine nucleoside phosphorylase (PNP)-deficiency with HLH. Some unusual features appeared when HLH was controlled and further investigations provided the correct diagnosis. Serum CXCL9 and IL-18 levels were found markedly elevated at disease onset, during the active phase of MAS and decreased progressively during the course.

Conclusion: The reported case underlines the potential difficulties in discriminating sJIA from other causes of systemic inflammation. Furthermore, this supports the notion that especially in young children with a sJIA-like disease other mimicking conditions should be actively sought for. CXCL9 and IL-18 levels suggested that patients with PNP-deficiency may have a subclinical activation of the IFNγ pathway and indeed they are predisposed to develop sHLH.

Citing Articles

Purine Nucleoside Phosphorylase Deficiency in Two Unrelated Patients with Autoimmune Hemolytic Anemia and Eosinophilia: Two Novel Mutations.

Alizadeh Z, Badalzadeh M, Heydarlou H, Shakerian L, Mahlooji Rad M, Zandieh F Arch Iran Med. 2024; 26(12):712-716.

PMID: 38431953 PMC: 10915924. DOI: 10.34172/aim.2023.105.


Biological and clinical roles of IL-18 in inflammatory diseases.

Landy E, Carol H, Ring A, Canna S Nat Rev Rheumatol. 2023; 20(1):33-47.

PMID: 38081945 DOI: 10.1038/s41584-023-01053-w.


Inborn Errors of Purine Salvage and Catabolism.

Camici M, Garcia-Gil M, Allegrini S, Pesi R, Bernardini G, Micheli V Metabolites. 2023; 13(7).

PMID: 37512494 PMC: 10383617. DOI: 10.3390/metabo13070787.


Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases.

Shimizu M, Takei S, Mori M, Yachie A Front Immunol. 2022; 13:951535.

PMID: 36211331 PMC: 9537046. DOI: 10.3389/fimmu.2022.951535.

References
1.
Yamamoto T, Moriwaki Y, Matsui K, Takahashi S, Tsutsui H, Yoshimoto T . High IL-18 (interferon-gamma inducing factor) concentration in a purine nucleoside phosphorylase deficient patient. Arch Dis Child. 1999; 81(2):179-80. PMC: 1718032. DOI: 10.1136/adc.81.2.179. View

2.
Wersto R, Chrest F, Leary J, Morris C, Stetler-Stevenson M, Gabrielson E . Doublet discrimination in DNA cell-cycle analysis. Cytometry. 2001; 46(5):296-306. DOI: 10.1002/cyto.1171. View

3.
Grunebaum E, Roifman C . Gene abnormalities in patients with hemophagocytic lymphohistiocytosis. Isr Med Assoc J. 2002; 4(5):366-9. View

4.
Petty R, Southwood T, Manners P, Baum J, Glass D, Goldenberg J . International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31(2):390-2. View

5.
Kawashima M, Novick D, Rubinstein M, Miossec P . Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis. Arthritis Rheum. 2004; 50(6):1800-5. DOI: 10.1002/art.20320. View